Lvm Capital Management LTD Eli Lilly & CO Transaction History

Lvm Capital Management LTD

$869 Million
Q3 2024

A detailed history of Lvm Capital Management LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Lvm Capital Management LTD holds 37,028 shares of LLY stock, worth $28 Million. This represents 3.78% of its overall portfolio holdings.

Number of Shares

37,028

Previous 37,028 -0.0%

Holding current value

$28 Million

Previous $33.5 Million 2.15%

% of portfolio

3.78%

Previous 3.82%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $583,520 - $731,777	-805 Reduced 2.13%	37,028 $33.5 Million
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $41,454 - $55,459	-70 Reduced 0.18%	37,833 $29.4 Million
Q4 2023 Jan 12, 2024	BUY	$525.19 - $619.13 $666,991 - $786,295	1,270 Added 3.47%	37,903 $22.1 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $106,501 - $146,828	-245 Reduced 0.66%	36,633 $19.7 Million
Q2 2023 Jul 07, 2023	SELL	$350.74 - $468.98 $140,296 - $187,592	-400 Reduced 1.07%	36,878 $17.3 Million
Q1 2023 Apr 17, 2023	SELL	$310.63 - $364.82 $5,901 - $6,931	-19 Reduced 0.05%	37,278 $12.8 Million
Q4 2022 Jan 03, 2023	SELL	$321.55 - $374.67 $234,731 - $273,509	-730 Reduced 1.92%	37,297 $13.6 Million
Q3 2022 Oct 05, 2022	BUY	$296.48 - $337.87 $22,828 - $26,015	77 Added 0.2%	38,027 $12.3 Million
Q2 2022 Jul 14, 2022	SELL	$278.73 - $327.27 $832,845 - $977,882	-2,988 Reduced 7.3%	37,950 $12.3 Million
Q1 2022 Apr 13, 2022	BUY	$234.69 - $291.66 $608,316 - $755,982	2,592 Added 6.76%	40,938 $11.7 Million
Q4 2021 Jan 04, 2022	SELL	$224.85 - $279.04 $112,425 - $139,520	-500 Reduced 1.29%	38,346 $10.6 Million
Q3 2021 Oct 05, 2021	BUY	$221.6 - $272.71 $3,324 - $4,090	15 Added 0.04%	38,846 $8.98 Million
Q2 2021 Jul 08, 2021	SELL	$180.55 - $233.54 $163,397 - $211,353	-905 Reduced 2.28%	38,831 $8.91 Million
Q1 2021 Apr 06, 2021	SELL	$164.32 - $212.72 $71,972 - $93,171	-438 Reduced 1.09%	39,736 $7.42 Million
Q4 2020 Jan 11, 2021	SELL	$130.46 - $172.63 $30,658 - $40,568	-235 Reduced 0.58%	40,174 $6.78 Million
Q3 2020 Oct 05, 2020	SELL	$146.22 - $169.13 $16,084 - $18,604	-110 Reduced 0.27%	40,409 $5.98 Million
Q2 2020 Jul 13, 2020	SELL	$136.42 - $164.18 $40,243 - $48,433	-295 Reduced 0.72%	40,519 $6.65 Million
Q4 2019 Jan 15, 2020	BUY	$106.92 - $132.43 $18,711 - $23,175	175 Added 0.43%	40,814 $5.36 Million
Q3 2019 Oct 04, 2019	SELL	$106.79 - $116.16 $10,679 - $11,616	-100 Reduced 0.25%	40,639 $4.54 Million
Q2 2019 Jul 02, 2019	SELL	$110.79 - $129.32 $66,474 - $77,592	-600 Reduced 1.45%	40,739 $0
Q4 2018 Jan 14, 2019	SELL	$105.9 - $118.64 $48,714 - $54,574	-460 Reduced 1.1%	41,339 $4.78 Million
Q3 2018 Oct 05, 2018	SELL	$85.86 - $107.31 $38,121 - $47,645	-444 Reduced 1.05%	41,799 $0
Q2 2018 Jul 10, 2018	SELL	$75.7 - $86.88 $98,410 - $112,944	-1,300 Reduced 2.99%	42,243 $0
Q1 2018 Apr 16, 2018	SELL	$74.21 - $87.6 $67,902 - $80,154	-915 Reduced 2.06%	43,543 $0
Q4 2017 Jan 11, 2018	SELL	$81.94 - $87.89 $49,164 - $52,734	-600 Reduced 1.33%	44,458 $0
Q3 2017 Oct 16, 2017	BUY	$77.07 - $85.54 $3.47 Million - $3.85 Million	45,058	45,058 $0

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $717B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvm Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lvm Capital Management LTD with notifications on news.

Account

Lvm Capital Management LTD Eli Lilly & CO Transaction History